PATENT CLAIM ANALYSIS

Application Number: 15564969
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-03
Patent Classification: ["424", "135100"]

Abstract:
The present invention provides, among other things, methods and compositions for treating chronic lung disorders, in particular, bronchopulmonary dysplasia (BPD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to BPD an effective amount of an anti-Flt-1 antibody, or antigen binding fragment thereof, such that at least one symptom or feature of BPD is reduced in intensity, severity, or frequency, or has delayed onset.

Claim (Index 31):
The method of any one of the preceding claims, wherein the administration of the anti-Flt-1 antibody or antigen binding fragment thereof results in growth of healthy lung tissue, decreased lung inflammation, increased alveologenesis, increased angiogenesis, improved structure of pulmonary vascular bed, reduced lung scarring, improved lung growth, reduced respiratory insufficiency, improved exercise tolerance, reduced adverse neurological outcome, and/or improved pulmonary function relative to a control.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14763881', '12069757', '14605649', '11277121', '12220245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.693841469269613
- 35 USC 102 Novelty (BERT): 0.5459623304483638
- Combined Prediction Score: 0.6790535553874881
- Mean Citation Score: 284.565086
- Max Citation Score: 380.26782
- Similarity Product: 309.1226373317814

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test